Asthma, a chronic inflammatory disorder of the airways, continues to affect millions worldwide. The past decade has witnessed significant advancements in its management, enhancing our understanding and treatment strategies for this complex disease.
Biological therapies have emerged as a promising approach in managing severe asthma. Monoclonal antibodies like Omalizumab, Mepolizumab, and Benralizumab target specific inflammatory pathways, reducing exacerbations and improving lung function. These biologics offer personalized treatment options based on the patient's phenotype and endotype.
Smart inhalers, equipped with sensors and Bluetooth technology, have revolutionized asthma management by improving medication adherence and providing real-time data on inhaler use. This technology allows healthcare professionals to monitor patients' inhaler technique and adherence, leading to improved disease control.
Telemedicine has proven to be an effective strategy in asthma management, especially during the COVID-19 pandemic. Remote patient monitoring and teleconsultations offer continued care, reduce hospital visits, and provide education on self-management strategies.
Machine learning algorithms can predict asthma exacerbations, identify phenotypes, and personalize treatment plans. This technology is still in its infancy but holds immense potential in transforming asthma care.
These advancements in asthma management emphasize the shift towards personalized, technology-driven care. Healthcare professionals must stay abreast of these developments to provide optimal care for asthma patients. The future of asthma management lies in further understanding the disease's heterogeneity, developing more targeted treatments, and leveraging technology for improved patient outcomes.
1.
FDA Expands Use of T-DXd in Early HER2+ Breast Cancer
2.
younger kidney cancer survivors are more susceptible to heart problems.
3.
Gene therapy for glioblastoma is effectively created by researchers.
4.
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?
5.
Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends
1.
Hematopoietic Aging and Long-Term Disease Risk: Mechanisms, Clinical Impact, and Emerging Therapeutic Strategies
2.
Clinical Guidance for Survivorship-Focused Cancer Care
3.
Transformative Insights in Oncology in Daily Practice
4.
Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes
5.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation